MedTrace Logo

Study Watch Atrial Fibrillation (AF) Detection Investigation

NCT04074434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2019-09-03

No results posted yet for this study

Summary

This is a prospective, non-randomized study to refine the Study Watch's algorithm for AF detection within both persistent and paroxysmal AF subjects. The study will also collect data from an FDA-cleared wearable ECG sensor.

Conditions

Interventions

DEVICE

Study Watch

Study Watch is a miniaturized physiological data monitoring and data collection device for continuous recording of physiological and environmental data

Sponsors & Collaborators

  • Verily Life Sciences LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-12
Primary Completion
2019-07-17
Completion
2019-07-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04074434 on ClinicalTrials.gov